Cadrenal Therapeutics, Inc. Stock Issued During Period, Shares, Period Increase (Decrease)
Cadrenal Therapeutics, Inc. (CVKD) had Stock Issued During Period, Shares, Period Increase (Decrease) of 306.97 thousand shares as of 2024-07-29, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease · last filed 2026-08-13
- 2024-07-29: Stock Issued During Period, Shares, Period Increase (Decrease) 306.97K shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) |
|---|---|
| 2024-07-29 | 306.97K shares 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |